Heterogeneity is rife in all tumours and we’re excited to explore drug distribution with other drug/cancer combinations, and the implications for efficacy and resistance. Finally, a huge thank you to the Fets Lab members, all collaborators and of course the patients. We’d love to hear any feedback!

….and shows heterogenous accumulation even within cell line models— a perfect tool to dig deeper.